Other News

EP Solutions’ Scientific and Mathematics Advisory Boards Endorse Company Strategy

YVERDON-LES-BAINS, Switzerland, March 29, 2018 /PRNewswire/ — Dr. Joaquin Azpilicueta, M.D., EP Solutions CEO reports the outcome of the meetings with the Scientific Advisory Board and the Mathematics Advisory Board celebrated in February and March 2018 respectively. The Scientific Advisory Board, with members that hold prominent positions in the cardiac electrophysiology community like Prof. Dr. Claudio Tondo, […]

Inari Medical Announces Completion of $27 Million Series C Financing

IRVINE, Calif., March 29, 2018 /PRNewswire/ — Inari Medical, Inc., announced today the close of a Series C financing totaling $27.0 million.  The financing was led by new investor Gilde Healthcare and was joined by all of Inari’s existing investors including Versant Ventures and U.S. Venture Partners.  Geoff Pardo of Gilde Healthcare will join Inari’s Board […]

IDx Founder Awarded Patent for System that Automatically Detects Measure of Cardiovascular Health

IOWA CITY, Iowa, March 29, 2018 /PRNewswire/ — IDx, a privately-held AI diagnostics company, today announced its founder and president, Michael Abramoff, MD, PhD, has been awarded U.S. Patent No. 9,924,867 for a system that can automatically measure arterial and venous diameters in blood vessels, an important predictor of cardiovascular health.  “It is exciting that […]

LivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients

LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has received CE Mark approval for its Bicarbon® aortic valves for use with low-dose anticoagulant therapy. The expanded CE labeling means that a lower international normalized ratio (INR), the standardized index used to measure blood coagulability, can be […]

Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor

ABBOTT PARK, Ill., March 29, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced today the company has initiated the landmark GUIDE-HF clinical trial using the CardioMEMS™ HF System. The GUIDE-HF trial will study whether the CardioMEMS device can improve survival and quality of life for people living with New York Heart Association (NYHA) Class II – IV heart failure. The […]

The global cardiac resynchronization therapy (CRT) market is expected to reach USD 9.2 billion by 2025

LONDON, March 28, 2018 /PRNewswire/ — Download the full report: https://www.reportbuyer.com/product/5360520 The global cardiac resynchronization therapy (CRT) market is expected to reach USD 9.2 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiac disorders and rising incidences of heart failure are expected to boost the CRT market […]

Vascular Insights® Announces New Chief Financial Officer

QUINCY, Mass., March 28, 2018 /PRNewswire/ — Vascular Insights® announced that Lisa Gruttadauria has been appointed Chief Financial Officer. In her most recent positions with Vascular Insights® as Controller and Director of Finance, Lisa has been consistently judicious in her management of the Company’s assets, and an ally in the execution of the Company’s strategic initiatives. She […]

Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation

MARLBOROUGH, Mass., March 28, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the U.K. Court of Appeal dismissed Edwards Lifesciences‘ appeal and upheld a prior court decision that Edwards’ Sapien 3™ device infringes Boston Scientific patent EP (UK) 2 926 766 and that all claims of that patent are valid. “We […]

2018 Global Electrocardiograph (ECG) Market Report – Projected to Reach $7 Billion in 2022 from $5 Billion in 2016 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)– The “Global Electrocardiograph (ECG) Market Analysis (2017-2023)” report has been added to ResearchAndMarkets.com’s offering. Electrocardiograph (ECG) Market was valued at $5 billion in 2016, and is estimated to reach $7 billion by 2023, growing at a CAGR of 5.8% during the forecast period. Technological advancements of ECG devices such as their portability, […]

Intact Vascular Welcomes TOBA BTK Trial One-Year Clinical Study Results Publication in Catheterization and Cardiovascular Intervention

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue of Catheterization and Cardiovascular Intervention. This multi-center pilot study focused on collecting data supporting the safety and performance of the […]